The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2
Open accessAbstract
Inflammation associates with peripheral insulin resistance, which dysregulates nutrient homeostasis and leads to diabetes. Inflammation induces the expression of SOCS proteins. We show that SOCS1 or SOCS3 targeted IRS1 and IRS2, two critical signaling molecules for insulin action, for ubiquitin-mediated degradation. SOCS1 or SOCS3 bound both recombinant and endogenous IRS1 and IRS2 and promoted their ubiquitination and subsequent degradation in multiple cell types. Mutations in the conserved SOCS box of SOCS1 abrogated its interaction with the elongin BC ubiquitin-ligase complex without affecting its binding to IRS1 or IRS2. The SOCS1 mutants also failed to promote the ubiquitination and degradation of either IRS1 or IRS2. Adenoviral-mediated expression of SOCS1 in mouse liver dramatically reduced hepatic IRS1 and IRS2 protein levels and caused glucose intolerance; by contrast, expression of the SOCS1 mutants had no effect. Thus, SOCS-mediated degradation of IRS proteins, presumably via the elongin BC ubiquitin-ligase, might be a general mechanism of inflammation-induced insulin resistance, providing a target for therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“obesity-related insulin resistance could result from a diminution in insulin receptor substrate-1 (IRS-1) in animals, secondary to an increase in suppressor of cytokine signaling 3 (SOCS-3), which binds to IRS-1 and leads to its ubiquitylation and proteolysis in experimental animals [5]”
From Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects (2020) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,345
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H. H., Burks, D. J., Ren, J., Previs, S. F., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 860
SOCS Proteins: Negative Regulators of Cytokine Signaling
Krebs, D. L., & Hilton, D. J. (2001) · Stem Cells · doi:10.1634/stemcells.19-5-378 · Cited by 826
New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
Saltiel, A. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00239-2 · Cited by 688
Zhang, J., Farley, A., Nicholson, S. E., Willson, T. A., Zugaro, L. M., Simpson, R. J., Moritz, R. L., Cary, D., Richardson, R. T., Hausmann, G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2071 · Cited by 626
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 899
The Mechanisms of Insulin Action
White, M. F., & Copps, K. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00033-0 · Cited by 12
Ye, H.-M., Zhao, T., Wu, L., Cheng, J., & Tan, X.-Y. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.12.037 · Cited by 13
Deng, L., Wang, R., Li, H., Zhang, C., Zhao, L., & Zhang, M. H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01517 · Cited by 13
Kusumastuti, S. A., Nugrahaningsih, D. A. A., & Wahyuningsih, M. S. H. (2019) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2019.01052 · Cited by 13
Interleukin-1 antagonists for diabetes
Mandrup-Poulsen, T. R. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.804060 · Cited by 13
The role of microtubule‐associated protein 1S in SOCS3 regulation of IL‐6 signaling
Zou, T., Ouyang, L., Chen, L., Dong, W., Qiao, H., Liu, Y., & Qi, Y. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.10.055 · Cited by 13
Physiopathologie du syndrome métabolique
Jullien, D. (2008) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(08)70542-8 · Cited by 15
[Cutaneous Histoplasmosis and AIDS].
Reyes, M., Arenas, L. R., Pichardo, P., Fragoso, R. V., Torres, A., & Zacarías, R. (2003) · PubMed · Cited by 13
Extrahepatic hepatitis C virus after transplantation: Diabetes and renal dysfunction
Sabharwal, S., Delgado‐Borrego, A., & Chung, R. T. (2008) · Liver Transplantation · doi:10.1002/lt.21613 · Cited by 13
Suppression of FoxO1 Activity by Long-Chain Fatty Acyl Analogs
Zatara, G., Hertz, R., Shaked, M., Mayorek, N., Morad, E., Grad, E., Cahan, A., Danenberg, H. D., Unterman, T. G., & Bar‐Tana, J. (2011) · Diabetes · doi:10.2337/db11-0248 · Cited by 13
Filho, C., Carvalheira, J. B. C., Velloso, L. A., & Saad, M. J. A. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000200008 · Cited by 20
Voros, C., Papadimas, G. K., Mavrogianni, D., Koulakmanidis, A.-M., Athanasiou, D., Bananis, K., Athanasiou, A. I., Athanasiou, A. V., Papapanagiotou, I., Vaitsis, D., et al. (2025) · Genes · doi:10.3390/genes16091101 · Cited by 13
Neuroendocrine and Behavioral Consequences of Hyperglycemia in Cancer
Vasquez, J. H., & Borniger, J. C. (2020) · Endocrinology · doi:10.1210/endocr/bqaa047 · Cited by 12
Sobhon, P., Savedvanich, G., & Weerakiet, S. (2023) · Exploration of Medicine · doi:10.37349/emed.2023.00124 · Cited by 12
Story, D. J., & Stephens, J. M. (2006) · Obesity · doi:10.1038/oby.2006.148 · Cited by 12
The E3 ligase TRAF4 promotes IGF signaling by mediating atypical ubiquitination of IRS-1
Yu, W., Singh, R., Wang, Z., O’Malley, B. W., & Yi, P. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100739 · Cited by 12
Li, N., Gao, X., Pan, Y., Liu, B., Pang, J., Zhao, C., & Zeng, F. (2022) · Food & Function · doi:10.1039/d1fo04062f · Cited by 12
Obesidad, síndrome metabólico y su impacto en las enfermedades cardiovasculares
Contreras-Leal, E., & Santiago-Garcı́a, J. (2011) · Dialnet (Universidad de la Rioja) · doi:10.32776/revbiomed.v22i3.98 · Cited by 12
Zhang, L., Xu, C., Ma, Y., Zhu, K., Chen, X., Shi, Q., Su, W., & Zhao, H. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.10.014 · Cited by 12
Dumpati, R., Ramatenki, V., Vadija, R., Vellanki, S., & Vuruputuri, U. (2018) · Journal of Molecular Recognition · doi:10.1002/jmr.2706 · Cited by 11
Czajkowska, J. B., Shutty, B. G., & Zito, S. (2012) · Journal of Medical Case Reports · doi:10.1186/1752-1947-6-5 · Cited by 12
Jiang, Y., Biswas, S. K., & Steinle, J. J. (2014) · Europe PMC (PubMed Central) · Cited by 12
White, M. F., & White, M. F. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1028-7_2 · Cited by 12
Liu, J. J., Xin, B., Du, L., Chen, L., Long, Y., & Feng, G. (2023) · Hepatology · doi:10.1002/hep.32555 · Cited by 11
Breast Cancer Risk and Management in the Endocrine Clinic: A Comprehensive Review
Hawazie, A., & Druce, M. R. (2025) · Clinical Endocrinology · doi:10.1111/cen.15209 · Cited by 11
González, F., Mather, K. J., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00228.2020 · Cited by 12
Prakash, A., SAXENA, V. K., Kumar, R., Tomar, S., Singh, M. K., & Singh, G. (2021) · Tropical Animal Health and Production · doi:10.1007/s11250-021-02844-7 · Cited by 10
Boura‐Halfon, S., Shuster-Meiseles, T., Beck, A., Petrovich, K., Gurevitch, D., Ronen, D., & Zick, Y. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0072 · Cited by 11
Kempińska‐Podhorodecka, A., Wunsch, E., Milkiewicz, P., Stachowska, E., & Milkiewicz, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111912 · Cited by 11
Role of UPP pathway in amelioration of diabetes-associated complications
Gupta, A. K., Behl, T., Aleya, L., Rahman, M. H., Yadav, H. N., Pal, G., Kaur, I., & Arora, S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-12781-5 · Cited by 11
Sasi, W., Ye, L., Jiang, W. G., Mokbel, K., & Sharma, A. K. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1107-0 · Cited by 11
Chowdhury, A. I., & Bergsten, P. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.034 · Cited by 11
Emery, B., Butzkueven, H., Snell, C. E., Binder, M. D., & Kilpatrick, T. J. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.022 · Cited by 11
Xie, X., Fan, L., Wu, Q., Zeng, C., Chen, X., Wang, W., Zhang, C., & Chen, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1688392 · Cited by 11
LncRNA MEG3: Targeting the Molecular Mechanisms and Pathogenic causes of Metabolic Diseases
Luo, Y., Wang, H., Wang, L., Wu, W. L., Zhao, J., Li, X., Xiong, R., Ding, X., Yuan, D., & Yuan, C. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673268051231009075027 · Cited by 10
Berenji, E., Motlagh, A. V., Fathi, M., Esmaeili, M., Izadi, T., Rezvanian, P., Zanjirband, M., Safaeinejad, Z., & Nasr‐Esfahani, M. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-56524-1 · Cited by 12
Combined effects of progesterone and SOCS3 DNA methylation on T2DM: a case–control study
Wang, L., Mao, Z., Liu, X., Wei, D., Liu, P., Nie, L., Fan, K., Kang, N., Song, Y., Xu, Q., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01172-9 · Cited by 10
Asuk, A. A., Dasofunjo, K., Okafor, A., & Mbina, F. (2014) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2015/11766 · Cited by 10
Ehlers, K., Brand, T., Bangert, A., Hauner, H., & Laumen, H. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514000208 · Cited by 11
Johnson, J. A., Calo, S., Nair, L. T., IglayReger, H. B., Greenwald-Yarnell, M. L., Skorupski, J. C., Myers, M. G., & Bodary, P. F. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.06.002 · Cited by 10
Nakatani, H., Aoki, N., Okajima, T., Nadano, D., Flint, D., & Matsuda, T. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.109.077958 · Cited by 10
Effect of pioglitazone on metabolic features in endotoxemia model in obese diabeticdb/dbmice
Sharma, M., Mohapatra, J., Malik, U., Nagar, J., Chatterjee, A., Ramachandran, B., & Jain, M. R. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12450 · Cited by 10
Small heterodimer partner (SHP) contributes to insulin resistance in cardiomyocytes
Rodríguez‐Calvo, R., Chanda, D., Oligschlaeger, Y., Miglianico, M., Coumans, W. A., Barroso, E., Tajes, M., Luiken, J. J. F. P., Glatz, J. F. C., Vázquez‐Carrera, M., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.02.006 · Cited by 10
TRIM32 regulates insulin sensitivity by controlling insulin receptor degradation in the liver
Thakur, S., Rawat, P., Dehury, B., & Mondal, P. (2025) · EMBO Reports · doi:10.1038/s44319-024-00348-7 · Cited by 9
Burn injury-induced IRS-1 degradation in mouse skeletal muscle.
Lu, X.-M., Tompkins, R., & Fischman, A. J. (2013) · Europe PMC (PubMed Central) · Cited by 9
Park, S., Sm, H., Lee, J., Sung, S., & Kim, S. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881106081529 · Cited by 9
Suppressor of cytokine signaling and accelerated atherosclerosis in kidney disease.
Wesoły, J., Sikorski, K., Lee, C., & Bluyssen, H. A. R. (2010) · Acta Biochimica Polonica · doi:10.18388/abp.2010_2402 · Cited by 9
Karanastasis, G., & Mantzoros, C. S. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-985-1_1 · Cited by 9
Chapter 4 Role of Prolactin in Autoimmune Diseases
Bellis, A. D., Bizzarro, A., & Bellastella, A. (2008) · Technical report · doi:10.1016/s1571-5078(07)00204-8 · Cited by 9
Kim, B., Oh, S., van Golen, C. M., & Feldman, E. L. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.11.001 · Cited by 9
Mechanisms of Insulin Signal Transduction
Garvey, W. T. (2004) · Wiley eBooks · doi:10.1002/0470862092.d0301 · Cited by 10
TLR4 and prostaglandin pathways at the crossroads of endotoxemia-induced lipolysis
Chirivi, M., Abou-Rjeileh, U., Myers, M. N., Parales-Girón, J., Worden, L. C., Lock, A. L., & Contreras, G. A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1591210 · Cited by 8
Cruz, A. M., & Beall, C. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.567378 · Cited by 8
Suppressor of Cytokine Signaling, Skeletal Muscle, and Chronic Health Conditions
Spangenburg, E. E. (2007) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e3180a02fe6 · Cited by 8
Obesity and gut microbiota - what do we know so far?
da Silva-Junior, V. L., Lopes, F. D. A. M., Albano, R. M., de Souza, M. D. G. C., Barbosa, C. M. D. L., Maranhao, P. A., Bouskela, E., & Kraemer‐Aguiar, L. G. (2017) · Medical Express · doi:10.5935/medicalexpress.2017.04.01 · Cited by 10
Lü, M., Ma, L., Shan, P., Liu, A., Yu, X., Jiang, W., Wang, X., Zhao, X., Ye, X., & Wang, T. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110659 · Cited by 8
Hung, A., Leury, B. J., Sabin, M. A., Fahri, F., DiGiacomo, K., Lien, T., & Dunshea, F. R. (2020) · Animals · doi:10.3390/ani10091685 · Cited by 8
Antonova‐Koch, Y., Riehle, M. A., Arik, A. J., & Brown, M. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385095-9.00038-5 · Cited by 8
Underlying Pathways for Interferon Risk to Type II Diabetes Mellitus
Abdel‐Hamid, N. M., Jubori, T., Farhan, A., Mahrous, M., Gouri, A., Awad, E. M., & Breuss, J. M. (2013) · Current Diabetes Reviews · doi:10.2174/15733998113096660080 · Cited by 8
Ahmed, Q. L., Manzoor, S., TARIQ, M., Khalid, M., Ashraf, W., Parvaiz, F., & Imran, M. (2014) · Acta Virologica · doi:10.4149/av_2014_03_238 · Cited by 8
Scallop mantle extract inhibits insulin signaling in HepG2 cells
Kariya, T., Takahashi, K., Itagaki, D., & Hasegawa, Y. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.1061 · Cited by 7
Masood, K. I., Irfan, M., Masood, Q., Yameen, M., Jamil, B., Ram, N., Rao, S., Rottenberg, M. E., & Hasan, Z. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.13134 · Cited by 9
Mallu, A. C. T., Vasudevan, M., Allanki, S., Nathan, A. A., Ravi, M. M., Ramanathan, G. S., Pradeepa, R., Mohan, V., & Dixit, M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.08.007 · Cited by 8
Genetic contributions to Type 2 diabetes: recent insights
Sale, M. M., & Rich, S. S. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.2.207 · Cited by 8
Mechanisms of insulin signal transduction
Langlais, P. R., Mandarino, L. J., & Garvey, W. T. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch12 · Cited by 8
Starling-Soares, B., Coelho, M. M., Campolina, B. G., Duarte, C. K., & Maioli, T. U. (2026) · Obesity Reviews · doi:10.1111/obr.70092 · Cited by 7
Emamgholipour, S., Esmaeili, F., Shabani, M., Hasanpour, S. Z., Pilehvari, M., Mahmoudabadi, H. Z., Motevasseli, M., & Shanaki, M. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01247-5 · Cited by 8
Vemana, H. P., & Dukhande, V. V. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121935 · Cited by 6
Sarcopenia in Diabetes Mellitus
Sugimoto, K., Wang, C.-C., & Rakugi, H. (2016) · Springer eBooks · doi:10.1007/978-4-431-55720-3_16 · Cited by 7
Гасанов, М. З. (2021) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2021-25-1-47-58 · Cited by 7
Jensik, P. J., & Arbogast, L. A. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.10.017 · Cited by 7
Síndrome metabólico: Bases clínicas y fisiopatológicas para un enfoque terapéutico racional
Gonzalo Martínez, R., Rodrigo Alonso, K., & Victoria Novik, A. (2009) · Revista médica de Chile · doi:10.4067/s0034-98872009000500014 · Cited by 7
Degradation of human Lipin-1 by BTRC E3 ubiquitin ligase
Ishimoto, K., Hayase, A., Kumagai, F., Kawai, M., Okuno, H., Hino, N., Okada, Y., Kawamura, T., Tanaka, T., Hamakubo, T., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.159 · Cited by 7
Davidson, C., Tharmalingam, S., Niccoli, S., Nemec-Bakk, A. S., Khurana, S., Murray, A., Tai, T. C., Boreham, D. R., Khaper, N., & Lees, S. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231650 · Cited by 9
White, M. F. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch8 · Cited by 8
Emerging perspectives in proteostasis: bridging mechanisms and therapeutics for human diseases
Borlepawar, A., Neu, M., Ma, Z., Deshpande, A., Bühringer, H., Hajieva, P., Frey, N., & Rangrez, A. Y. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02714-4 · Cited by 7
Obesity and chronic leptin resistance foster insulin resistance
Dey, S., Murmu, N., Böse, M., Ghosh, S., & Giri, B. (2021) · BLDE University Journal of Health Sciences · doi:10.4103/bjhs.bjhs_29_20 · Cited by 9
Mathew, D., Barillas, J., Nedeljkovic-Kurepa, A., Abraham, M. N., Taylor, M. D., & Deutschman, C. S. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00703-9 · Cited by 6
Silencing ANGPTL8 reduces mouse preadipocyte differentiation and insulin signaling
Ghosh, A., Leung, Y. H., Yu, J. C., SLADEK, R. M., Chénier, I., Oppong, A. K., Peyot, M., Madiraju, S. R. M., Al‐Khairi, I., Thanaraj, T. A., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2024.159461 · Cited by 5
Chang, H.-H., Tsai, P.-H., Liu, C.-W., Ku, H., Kao, C.-C., & Kao, Y.-H. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.12.002 · Cited by 6
Tuberculosis and host metabolism: ancient associations, fresh insights
Blumenthal, A., Isovski, F., & Rhee, K. Y. (2009) · Translational research · doi:10.1016/j.trsl.2009.04.004 · Cited by 6
Guo, Q., Zheng, R., Huang, J., He, M. X., Wang, Y., Guo, Z., Sun, L., & Chen, P. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00663 · Cited by 6
Use of Silymarine as Adjuvant in Type 1 Diabetes Mellitus Patients Poorly Controlled with Insulin
Numan, A. T., Hadi, N. A., Mohammed, N. S., & Hussain, S. A. (2010) · Journal of the Faculty of Medicine Baghdad · doi:10.32007/jfacmedbagdad.5211063 · Cited by 6
From obesity through immunity to type 2 diabetes mellitus
Szablewski, L. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0531-4 · Cited by 5
Aerobic training reverses high-fat diet-induced pro-inflammatory signalling in rat skeletal muscle
Yaspelkis, B. B., Kvasha, I. A., Lessard, S. J., Rivas, D. A., & Hawley, J. A. (2010) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1559-7 · Cited by 6
Shooting the Messenger: CULLIN' Insulin Signaling with Fbw8
Mieulet, V., & Lamb, R. F. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.010 · Cited by 6
Muthiah, A., Angulo, M. S., Walker, N. N., Keller, S. R., & Lee, J. K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207325 · Cited by 6
Nelson, D. A., Thompson, K. J., Wang, L., Wang, Z., Eberts, P. M., Azarin, S. M., Kalari, K. R., & Kandimalla, K. K. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230907 · Cited by 6
SOCS2 Binds to and Regulates EphA2 through Multiple Mechanisms
Pilling, C., & Cooper, J. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-11040-3 · Cited by 5
Tung, Y., Chen, Y., Fan, T.-Y., Fong, T.-H., & Chiu, W. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20451 · Cited by 5
Dehennaut, V., & Lefebvre, T. (2013) · PROTEOMICS · doi:10.1002/pmic.201300363 · Cited by 5
Vargas‐Alarcón, G., Posadas‐Sánchez, R., Posadas‐Romero, C., González-Salazar, C., Cardoso-Saldaña, G. C., Martínez‐Ríos, M. A., Peña‐Duque, M. A., Obil-Chavarría, C. A., Pérez-Méndez, O. A., & Fragoso, J. M. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.019 · Cited by 5
Glycemic control in critically ill surgical patients: risks and benefits
May, A. K., Mukherjee, K., Albaugh, V. L., Richards, J. E., & Rumbaugh, K. A. (2015) · Open Access Surgery · doi:10.2147/oas.s50416 · Cited by 5
Adipocyte-hepatocyte crosstalk and the pathogenesis of nonalcoholic fatty liver disease #
Smith, B. W., George, J., Kowdley, K. V., McCaughan, G. W., & Trautwein, C. (2009) · Hepatology · doi:10.1002/hep.22937 · Cited by 5
Dai, B., & Zhang, X. (2020) · Neoplasma · doi:10.4149/neo_2020_190807n724 · Cited by 5
Muthiah, A., Angulo, M. S., Walker, N. N., Keller, S. R., & Lee, J. K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204100 · Cited by 5
Insulin signaling in the aging nervous system
Rocha, E. M., Fernandes, M. L., & Velloso, L. A. (2004) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(04)16005-7 · Cited by 5
Macronutrient intake, insulin secretion, oxidative stress & inflammation
Dandona, P., Ghanim, H., Chaudhuri, A., & Mohanty, P. (2016) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1807_16 · Cited by 5
Pathogenesis of Type 2 Diabetes
Stümvoll, M., Goldstein, B., & van Haeften, T. W. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-3 · Cited by 5
Regulation of Insulin Signaling through Protein Degradation
Lee, M.-Y., & Baek, K. (2005) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2005.20.5.434 · Cited by 5
Metadata
- Authors
- Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- White, Morris F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 277
- Issue
- 44
- Pages
- 42394-42398
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2069711307
- Cited by
- 904
- References
- 44
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 18 · 2023: 25 · 2022: 35 · 2021: 39 · 2020: 27 · 2019: 29 · 2018: 42 · 2017: 33 · 2016: 48 · 2015: 27 · 2014: 50 · 2013: 51 · 2012: 57
- FWCI
- 30.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- SOCS1, SOCS3, IRS-1, insulin receptor substrate 2, insulin signaling, ubiquitin-mediated proteolysis, SOCS box, inflammation, insulin resistance, impaired glucose tolerance, liver, diabetes mellitus
- MeSH terms
- Suppressor of Cytokine Signaling 1 Protein, Suppressor of Cytokine Signaling 3 Protein, Elongin, Animals, Carrier Proteins, Glucose, Homeostasis, Humans, Insulin Resistance, Male, Mice, Inbred C57BL, Phosphoproteins, Proteins, Repressor Proteins, Transcription Factors, Ubiquitin, Intracellular Signaling Peptides and Proteins, Suppressor of Cytokine Signaling Proteins, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review